Tenet Healthcare Files 8-K Report
Ticker: THC · Form: 8-K · Filed: Nov 3, 2025 · CIK: 70318
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: THC
TL;DR
Tenet Healthcare filed an 8-K on Nov 3, 2025, mostly procedural stuff.
AI Summary
On November 3, 2025, Tenet Healthcare Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates ongoing reporting requirements for Tenet Healthcare Corp. to the SEC, providing updates on company events and financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information that suggests immediate or significant risk.
Key Players & Entities
- TENET HEALTHCARE CORP (company) — Registrant
- November 3, 2025 (date) — Date of earliest event reported
- 14201 Dallas Parkway (address) — Principal executive offices
- Dallas, TX 75254 (address) — Principal executive offices zip code
FAQ
What is the primary purpose of this 8-K filing for Tenet Healthcare Corp.?
The filing is a Current Report on Form 8-K, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of November 3, 2025.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is November 3, 2025.
What is Tenet Healthcare Corp.'s state of incorporation and IRS Employer Identification Number?
Tenet Healthcare Corp. is incorporated in Nevada and has an IRS Employer Identification Number of 95-2557091.
What is the principal executive office address for Tenet Healthcare Corp.?
The principal executive offices are located at 14201 Dallas Parkway, Dallas, TX 75254.
What was Tenet Healthcare Corp.'s former name?
The former company name was NATIONAL MEDICAL ENTERPRISES INC /NV/, with a date of name change on July 3, 1992.
Filing Stats: 1,001 words · 4 min read · ~3 pages · Grade level 11.7 · Accepted 2025-11-03 17:26:53
Key Financial Figures
- $0.05 — nge on which registered Common stock, $0.05 par value THC NYSE 6.875% Senior Notes
- $1.5 billion — ement of private placement offerings of $1.5 billion in aggregate principal amount of its se
- $0.50 billion — r secured first lien notes due 2032 and $0.50 billion in aggregate principal amount of its se
- $0.75 billion — notes") and the upsizing and pricing of $0.75 billion in aggregate principal amount of its 6.
Filing Documents
- thc-20251103.htm (8-K) — 36KB
- thc-20251103exh991.htm (EX-99.1) — 12KB
- thc-20251103exh992.htm (EX-99.2) — 13KB
- tenethealth_rgba.jpg (GRAPHIC) — 109KB
- 0000070318-25-000048.txt ( ) — 382KB
- thc-20251103.xsd (EX-101.SCH) — 2KB
- thc-20251103_def.xml (EX-101.DEF) — 17KB
- thc-20251103_lab.xml (EX-101.LAB) — 29KB
- thc-20251103_pre.xml (EX-101.PRE) — 18KB
- thc-20251103_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On November 3, 2025 , Tenet Healthcare Corporation (the "Company") issued a press release announcing the commencement of private placement offerings of $1.5 billion in aggregate principal amount of its senior secured first lien notes due 2032 and $0.50 billion in aggregate principal amount of its senior notes due 2033. A copy of the press release is furnished as Exhibit 99.1 attached hereto and is incorporated herein by reference. Additionally, on November 3, 2025 , the Company issued a press release announcing pricing of $1.5 billion in aggregate principal amount of its 5.500% senior secured first lien notes due 2032 (the "first lien notes") and the upsizing and pricing of $0.75 billion in aggregate principal amount of its 6.000% senior notes due 2033 (the "senior notes" and together with the first lien notes, the "notes"). The closings of the sales of the notes are expected to occur on November 18, 2025, and are subject to customary closing conditions. A copy of the press release is furnished as Exhibit 99.2 attached hereto and is incorporated herein by reference. The first lien notes will be guaranteed by certain of the Company's subsidiaries and secured on a first lien priority basis by a pledge of the capital stock and other ownership interests of certain of the Company's subsidiaries. The first lien notes will be effectively senior to the Company's existing and future indebtedness secured on a more junior basis, as well as unsecured indebtedness and other liabilities, to the extent of the value of the collateral securing such borrowings. The senior notes will be the Company's unsecured obligations and will rank equally in right of payment with its existing and future senior unsecured obligations, will rank senior in right of payment to all of the Company's existing and future unsecured subordinated obligations, will be effectively subordinated to all of the Company's existing and future senior secured obligations, in
01
Item 8.01. Other Events. On November 3, 2025 , the Company issued a notice of conditional full redemption to the holders of its 2027 Notes and a notice of conditional partial redemption to the holders of its 2028 Notes. The 2027 Notes will be redeemed on November 19, 2025, and the 2028 Notes will be partially redeemed on November 19, 2025.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by the Company on November 3, 2025, announcing the commencement of the offering of the notes . 99.2 Press Release issued by the Company on November 3, 2025, announcing the pricing of the notes. 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: November 3, 2025 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary